Management of biological therapies for chronic plaque psoriasis during COVID‐19 emergency in Italy
Marina Talamonti(NorthShore University HealthSystem), Angelo Valerio Marzano(University of Milan), M. Lombardo(Ospedale di Circolo e Fondazione Macchi), Salvatore Cannavò, Francesco Loconsole(University of Bari Aldo Moro), Andrea Chiricozzi(University of Pisa), Claudio Feliciani(University of Parma), Annamaria Offidani(Marche Polytechnic University), Gabriella Fabbrocini(University of Naples Federico II), Andrea Conti(Policlinico di Modena), Paola Savoia(University of Turin), Luca Stingeni(University of Perugia), Paolo D. Pigatto(University of Milan), Marina Venturini(University of Brescia), Anna Belloni Fortina(University of Padua), Paolo Amerio(Sunnybrook Health Science Centre), Marco Galluzzo(University of Rome Tor Vergata), Alessandro Parodi(Ospedale Policlinico San Martino), Maria Concetta Fargnoli(University of L'Aquila), Concetta Potenza(Sapienza University of Rome), Maria Rita Bongiorno(University of Palermo), Federico Bardazzi(University of Bologna), Pietro Quaglino(Department of Medical Sciences), Giuseppe Argenziano, Andrea Carugno(University of Insubria), Pietro Rubegni(University of Siena), Steven Paul Nisticò(Magna Graecia University), Giuseppe Micali(University of Catania), Francesca Prignano(University of Florence), Sandra Giustini(Sapienza University of Rome), Iris Zalaudek(University of Trieste), Paolo Gisondi(University of Verona), Franco Rongioletti(University of Cagliari), Luca Bianchi(University of Rome Tor Vergata), Ketty Peris(Università Cattolica del Sacro Cuore)
Cited by 32
Related Papers
The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria
|Allergy|2021|1.2k
The Immunologic Role of IL-17 in Psoriasis and Psoriatic Arthritis Pathogenesis
|Clinical Reviews in Allergy & Immunology|2018|738
Diagnosis and treatment of basal cell carcinoma: European consensus–based interdisciplinary guidelines
|European Journal of Cancer|2019|589
Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial
|The Lancet|2017|580
Treatment of Fabry’s Disease with the Pharmacologic Chaperone Migalastat
|New England Journal of Medicine|2016|555